
Contact HIV/AIDS
Info on HIV/AIDS:
206-205-7837
TTY: 206-296-4843
Toll-free: 800-678-1595
Administration:
206-296-4649
HIV/STD Testing
HIV/STD Hotline:
206-205-7837 or
Toll-free: 800-678-1595
11:00 am to 4:00 pm
Monday - Friday for
testing information, resources and referrals
|
|
HIV/AIDS Program
Bibliographies for February 2002
| 1. |
Kirby D. Understanding What Works and What Doesn't in Reducing Adolescent Sexual Risk-Taking. Family Planning Perspectives, Nov/Dec. 2001; 33(6): 276-281. |
| 2. |
Russell ST, Driscoll AK and Truong N. Adolescent Same-Sex Romantic Attractions and Relationships: Implications for Substance Use and Abuse. American Journal Public Health, Feb. 2002; 92(2): 198-202. |
| 3. |
Goodenow C, Netherland J and Szalacha L. AIDS-Related Risk Among Adolescent Males Who Have Sex With Males, Females, or Both: Evidence from a Statewide Survey. American Journal Public Health, Feb. 2002; 92(2): 203-210. |
| 4. |
O'Donnell L, O'Donnell CR and Stueve A. Early Sexual Initiation and Subsequent Sex-Related Risks Among Urban Minority Youth: The Reach for Health Study. Family Planning Perspectives, Nov/Dec 2001; 33(6): 268-275. |
| 5. |
Siegel DM, Aten MJ and Enaharo M. Long-Term Effects of a Middle School and High School Based HIV Sexual Risk Prevention Intervention. Arch Pediatr Adoles Med, Oct 2001; 155: 1117-1126. |
| 6. |
Connett, H (Editor). Abstinence Ed at Four Years: Mixed Bag, Mixed Results. STD Advisor, Nov 2001; 4(11):113-124. |
| 7. |
DiClemente RJ, Wingood GM, Crosby RA et al. Sexual Risk Behaviors Associated With Having Older Sex Partners: A Study of Black Adolescent Females. Sexually Transmitted Diseases, Jan 2002; 29(1): 20-24. |
| 8. |
Marx MA, Brahmbhatt H Beilenson P, Brookmeyer RS, Strathdee SA, Alexander C and Vlahov D. Impact of Needle Exchange Programs on Adolescent Perceptions about Illicit Drug Use. AIDS and Behavior, 2001; 5(4): 379-386. |
| 9. |
Lifson AR and Halcon LL. Substance Abuse and High-Risk Needle-Related Behaviors among Homeless Youth in Minneapolis: Implications for Prevention. Journal of Urban Health, Dec 2001; 78(4): 690-698. |
| 10. |
Levine AM. Evaluation and Management of HIV-Infected Women. Annals of Internal Medicine, Feb 5, 2002;136(3):228-242. |
| 11. |
Tross S. Women at Heterosexual Risk for HIV in Inner-City New York: Reaching the Hard to Reach. AIDS and Behavior, 2001; 5(2): 131-139. |
| 12. |
Hogben M, Gange SJ, Watts DH et al. The Effect of Sexual and Physical Violence on Risky Sexual Behavior and STDs Among a Cohort of HIV Seropositive Women. AIDS and Behavior, 2001; 5(4): 353-361. |
| 13. |
Latka M. Female-Initiated Barrier Methods for the Prevention of STI/HIV: Where Are We Now? Where Should We Go? Journal of Urban Health, Dec 2001; 78(4): 571-580. |
| 14. |
Raphan G, Cohen S and Boyer AM. The Female Condom, a Tool for Empowering Sexually Active Urban Adolescent Women. Journal of Urban Health, Dec 2001; 78(4): 605-613. |
| 15. |
Villanueva JM, Ellerbrock TV, Lennox JL et al. The Menstrual Cycle Does Not Affect HIV-1 Levels in Vaginal Secretions. Journal of Infectious Diseases, Jan 15, 2002;185: 170-177. |
| 16. |
Smith JB, Nkhama G and Trottier DA. Female Condom Reuse in Lusaka, Zambia: Evidence from 12 Cases. Journal of Urban Health, Dec 2001; 78(4): 638-646. |
| 17. |
Clatts MC, Welle DL and Goldsamt LA. Reconceptualizing the Interaction of Drug and Sexual Risk Among MSM Speed Users: Notes Toward an Ethno-Epidemiology. AIDS and Behavior, 2001; 5(2): 115-130. |
| 18. |
Suarez T and Miller J. Negotiating Risks in Context: A Perspective on Unprotected Anal Intercourse and Barebacking Among Men Who Have Sex With Men-Where Do We Go From Here? Archives of Sexual Behavior, 2001; 30(3): 287-300. |
| 19. |
Osmond DH, Buchbinder S, Cheng A et al. Prevalence of Kaposi Sarcoma-Associated Herpesvirus Infection in Homosexual Men at Beginning of and During the HIV Epidemic. Journal American Medical Association, Jan 9, 2002; 287(2): 221-225. |
| 20. |
Carr GS. Primary Care of Anally Receptive Men. Journal Assoc Nurses AIDS Care, Jan/Feb 2002; 13(1): 81-86. |
| 21. |
Wolitski RJ, Halkitis PN, Parsons JT and Gomez CA. Awareness and Use of Untested Barrier Methods by HIV-Seropositive Gay and Bisexual Men. AIDS Education and Prevention, 2001; 13(4): 291-301. |
| 22. |
MacKellar DA, Valleroy LA Secura GM, Perdue TE et al for the Young Men's Survey Study Group. Repeat HIV Testing, Risk Behaviors, and HIV Seroconversion Among Young Men Who Have Sex With Men: A Call to Monitor and Improve the Practice of Prevention. JAIDS, Jan 1, 2002; 29(1): 76-85. |
| 23. |
Dilorio C, Harwell T, and Hansen N for the NIMH Multisite HIV Prevention Trial Group. Childhood Sexual Abuse and Risk Behaviors Among Men at High Risk for HIV Infection. Amer Journal Public Health, Feb 2002; 92(2): 214-219.
|
| 24. |
Mbori-Ngacha D, Nduati R, John G et al. Morbidity and Mortality in Breastfed and Formula-Fed Infants of HIV-1-Infected Women. JAMA, Nov 21, 2001; 286(19): 2413-2420.
|
| 25. |
Hanna L. The Dilemma of Breast-Feeding. BETA, Winter, 2002; 15(1): 36-45. |
| 26. |
Mialky E, Vagnoni J and Rutstein R. School-Age Children with Perinatally Acquired HIV Infection: Medical and Psychosocial Issues in a Philadelphia Cohort. AIDS Patient Care & STDs, 2001; 15(11): 575-579. |
| 27. |
Mokotoff ED, Malamud BH, Kent JB et al. Progress Toward Elimination of Perinatal HIV Infection-Michigan, 1993-2000. MMWR, Feb 8, 2002; 51(05): 94-97. |
| 28. |
Nicholas SW and Abrams EJ. Boarder Babies with AIDS in Harlem: Lessons in Applied Public Health. (Editorial) Amer Journal Public Health, Feb 2002; 92(2): 163-165.
|
| 29. |
Gilborn LZ. Beyond Our Borders: The Effects of HIV Infection and AIDS on Children in Africa. West. Journal Medicine, Jan 2002; 176: 12-14. |
| 30. |
Gortmaker SL, Hughes M, Cervia J et al for the Pediatric AIDS Clinical Trials Group Protocol 219 Team. Effect of Combination Therapy Including Protease Inhibitors on Mortality Among Children and Adolescents Infected with HIV-1. New England Journal Medicine, Nov 22, 2002; 345(21): 1522-1528. |
| 31. |
Verweel G, van Rossum AMC, Hartwig NC et al. Treatment with Highly Active Antiretroviral Therapy in HIV-1 Infected Children is Associated with a Sustained Effect on Growth. Pediatrics, Feb 2002; 109(2): 7 pages. |
Sexually Transmitted Diseases
|
| 32. |
Turner CF, Rogers SM, Miller HG et al. Untreated Gonococcal and Chlamydial Infection in a Probability Sample of Adults. JAMA, Feb 13, 2002; 287(6): 726-733. |
| 33. |
Fortenberry JD. Unveiling the Hidden Epidemic of Sexually Transmitted Diseases. (Editorial) JAMA, Feb 13, 2002; 287(6): 768-769. |
| 34. |
Wald A, Langenberg AGM, Link K et al. Effect of Condoms on Reducing the Transmission of Herpes Simplex Virus Type 2 From Men to Women. JAMA, June 27, 2001; 85(24): 3100-3106. |
| 35. |
Wald A and Link K. Risk of HIV Infection in Herpes Simplex Virus Type 2 Seropositive Persons: A Meta-Analysis. Journal of Infectious Diseases, Jan 1, 2002; 185: 45-52. |
| 36. |
Ahmed S, Lutalo T, Wawer M et al. HIV Incidence and Sexually Transmitted Disease Prevalence Associated with Condom Use: a Population Study in Rakai, Uganda. AIDS, 2001; 15:2171-2179. |
| 37. |
Moodley P, Connolly C and Sturm AW. Interrelationships among HIV-1 Infection, Bacterial Vaginosis, Trichomoniasis, and the Presence of Yeasts. Journal of Infectious Diseases, Jan 1, 2002; 185: 69-73. |
| 38. |
Schwebke JR and Weiss HL. Interrelationships of Bacterial Vaginosis and Cervical Inflammation. Sexually Transmitted Diseases, Jan 2002; 29(1): 59-64. |
| 39. |
Stamm WE. Chlamydia trachomatis -The Persistent Pathogen. (Thomas Parran Award Lecture) Sexually Transmitted Diseases, Dec 2001; 28(12): 684-689.
|
| 40. |
Andersen B, Olesen F, Moller JK and Ostergaard L. Population-Based Strategies for Outreach Screening of Urogenital Chlamydia trachomatis Infections: A Randomized, Controlled Trial. J Infectious Dis, Jan 15, 2002; 185: 252-258. |
| 41. |
Rottingen J-A, Cameron DW and Garnett GP. A Systematic Review of the Epidemiologic Interactions Between Classic STDs and HIV: How much is really known? Sexually Transmitted Diseases, Oct 2001; 28(10): 579-597. |
| 42. |
Korenromp EL, de Vlas SJ, Nagelkerke JD and Habbema JDF. Estimating the Magnitude of STD Cofactor Effects on HIV Transmission: How well can it be done? Sexually Transmitted Diseases, Nov 2001; 28(11): 613-621. |
| 43. |
Weinstock H, Dale M, Linley L and Gwinn M. Unrecognized HIV Infection Among Patients Attending STD Clinics. AJPH, Feb 2002; 92(2): 280-283. |
Care and Treatment of HIV Infection
|
| 44. |
Lori F and Lisziewicz J. Structured Treatment Interruptions for the Management of HIV Infection. JAMA, Dec 19, 2001; 286(23): 2981-2987.
|
| 45. |
Burkle WS. Antiretroviral Therapy for HIV: Drug Resistance and Sequencing. J Assoc Nurses AIDS Care, Jan/Feb 2002; 13(1): 76-80.
|
| 46. |
James JS. HIV Resistance: Data and Spin. AIDS Treatment News, Dec 28, 2001; #376: 2-4. |
| 47. |
Blower S. Transmission of Zidovudine Resistant Strains of HIV-1: The First Wave. (Editorial Comment) AIDS, 2001; 15(17): 2317-2318. |
| 48. |
Piscitelli SC, Burstein AH, Welden N, Gallicano KD and Falloon J. The Effect of Garlic Supplements on the Pharmacokinetics of Saquinavir. Clinical Infectious Diseases, Jan 15, 2002; 34: 234-238. |
| 49. |
Swica Y and Breitbart W. Treating Pain in Patients with AIDS and a History of Substance Use. Western Journal of Medicine, 2002; 176: 33-39. |
| 50. |
Treisman GJ, Angelino AF and Hutton HE. Psychiatric Issues in the Management of patients with HIV Infection. JAMA, Dec 12, 2001; 286(22): 2857-2864. |
| 51 |
Levine JM. Psychiatric Aspects of HIV Care. AIDS Clinical Care, Nov 2001; 13(11): 101-109. |
HIV Counseling and Testing
|
| 52. |
Spielberg F, Kurth A, Gorbach PM and Goldbaum G. Moving from Apprehension to Action: HIV Counseling and Testing Preferences in Three At-Risk Populations. AIDS Education and Prevention, 2001; 13(6): 524-540. |
| 53. |
Riess TH, Kim C and Downing M. Motives for HIV Testing Among Drug Users: An Analysis of Gender Differences. AIDS Education and Prevention, 2001; 13(6): 509-523. |
| 54. |
Centers for Disease Control and Prevention. HIV Counseling and Testing in Publicly Funder Sites Annual Report 1997 and 1998. Centers for Disease Control and Prevention, 2001. |
| 55. |
Crepaz N and Marks G. Towards an Understanding of Sexual Risk Behavior in People Living with HIV: A Review of Social, Psychological, and Medical Findings. (Editorial Review) AIDS, 2002; 16(2): 135-149. |
| 56. |
Mitchell CG and Linsk NL. Prevention for Positives: Challenges and Opportunities for Integrating Prevention into HIV Case Management. AIDS Education and Prevention, 2001; 13(5): 393-402. |
| 57. |
Margolis AD, Wolitski RJ, Parsons JT and Gómez CA. Are Healthcare Providers Talking to HIV-Seropositive Patients About Safer Sex? (Research Letter) AIDS, 2001; 15(17): 2335-2337. |
| 58. |
Ford K, King G Nerenberg L and Rojo C. AIDS Knowledge and Risk Behaviors Among Midwest Migrant Farm Workers. AIDS Ed 7 Prev, 2001; 13(6): 551-560. |
| 59. |
Newman JC, Des Jarlais DC, Turner CF, Gribble J, Cooley P and Paone D. The Differential Effects of Face-to-Face and Computer Interview Modes. AJPH, Feb 2002; 92(2): 294-297. |
| 60. |
Van de Wijgert J and Coggins C. Microbicides to Prevent Heterosexual Transmission of HIV: Ten Years Down the Road. AIDScience, Jan 18, 2002; 2(1): 10 pages. |
| 61. |
Lamptey PR. Reducing Heterosexual Transmission of HIV in Poor Countries. (Clinical Review) BMJ, Jan 26 2002; 324: 207-211. |
| 62. |
New York City Dept. of Health, Epidemiology Group. 25 Years of HIV in New York City: Lessons from Surveillance. Journal of Urban Health, Dec 2001; 78(4): 669-678. |
| 63. |
Harris VL. Society's Disposable People: HIV Serostatus, Sexual Orientation, and Incarcerated. Journal Gay & Lesbian Med Assoc, 2001; 5(3): 107-113. |
| 64. |
Klein SJ, Harris-Valente K, Candelas AR et al. What Do Pharmacists Think About New York State's New Nonprescription Syringe Sale Program? Results of a Survey. J Urban Health, Dec 2001; 78(4): 679-689. |
| 65. |
Tatt ID, Barlow KL, Nicoll A and Clewley JP. The Public Health Significance of HIV-1 Subtypes. AIDS, 2001; 15(suppl 5): S59-S71. |
| 66. |
Bock PJ and Markovitz DM. Infection with HIV-2. AIDS, 2001; 15(suppl 5): S35-S45. |
| 67 |
Pomerantz RJ. Reservoirs of HIV-1: The Main Obstacles to Viral Eradication. Clinical Infectious Dis, Jan 1 2002; 34: 91-97. |
Lancet Epidemiology Series
|
| 68. |
Grimes DA and Schulz KF. An Overview of Clinical Research: The Lay of the Land. Lancet, Jan 5, 2002; 359:57-61. |
| 69. |
Grimes DA and Schulz KF. Descriptive Studies: What They Can and Cannot Do. Lancet, Jan 12, 2002; 359: 145-149. |
| 70. |
Gimes DA and Schulz KF. Bias and Causal Associations in Observational Research. Lancet, Jan 19, 2002; 359: 248-252. |
| 71. |
Grimes DA and Schulz KF. Cohort Studies: Marching Towards Outcomes. Lancet, Jan 26, 2002; 359: 341-345. |
| 72. |
Schulz KF and Grimes DA. Case-Control Studies: Research in Reverse. Lancet, Feb 2, 2002; 359: 431-434. |
|
|
|